Vaccinations
Filters
ResetWe found 5 products for you!

SHINGRIX Herpes Zoster/Shingles (Recombinant, adjuvanted) Vaccine
A total of 2 doses are required to complete the vaccination schedule:
- 2 doses separated by 2-6 months

AREXVY Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted
For individuals aged 60 or above:
How:
- Intramuscular Injection
- Single-dose administration

Shingles Vaccination (Shingrix)
Who should get Shingrix?
- All healthy adults aged 50 or above. You should get Shingrix vaccination even if you:
- have had Shingles
- received the other shingles vaccine ‘Zostavax’
- are not sure if you had chickenpox in the past

Respiratory Syncytial Virus (RSV) Vaccine
Recommended:
Recommendations for individuals aged 60 and above, especially those with chronic illnesses, to receive early vaccination:
- Only one dose is required, effectively reducing the risk of RSV infection and the likelihood of developing complications after infection.
- 82.6% efficacy*: Protects against lower respiratory tract diseases caused by respiratory syncytial virus (RSV).
- 94.6% efficacy*: Protects individuals with at least one coexisting condition.

New Generation Shingles Vaccination (2 doses)
New Generation Shingles Vaccination (2 doses)
The shingles vaccine is designed to prevent infections caused by the varicella-zoster virus. It is suitable for high-risk individuals aged 18 and older, as well as those aged 50 and above. The vaccine effectively reduces the risk of shingles and its associated post-herpetic neuralgia, decreasing the likelihood of other complications. After vaccination, patients can achieve over 90% protection, which is particularly important for those who have previously had chickenpox. Common side effects include pain at the injection site, muscle pain, and mild fatigue.